TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Dawnrays Pharmaceutical Holdings Ltd. ( (HK:2348) ) is now available.
Dawnrays Pharmaceutical Holdings Ltd. has announced the composition of its board of directors, which includes executive, non-executive, and independent non-executive directors. The board has also established three committees: Audit, Remuneration, and Nomination, with specific directors assigned roles as chairmen or members. This announcement outlines the governance structure of the company, which is crucial for stakeholders to understand the leadership and decision-making processes within the organization.
More about Dawnrays Pharmaceutical Holdings Ltd.
Dawnrays Pharmaceutical Holdings Ltd. is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It focuses on the development, manufacturing, and sale of pharmaceutical products.
Average Trading Volume: 2,157,732
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$2.13B
For detailed information about 2348 stock, go to TipRanks’ Stock Analysis page.